Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Doxil in Platinum-Resistant Ovarian Cancer
NCT00945139Phase 2Completed
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Mar 2007
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in ovarian cancer, sponsored by New Mexico Cancer Research Alliance. Started Mar 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00945139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945139.